Form 8-K - Current report:
SEC Accession No. 0001559053-20-000045
Filing Date
2020-12-09
Accepted
2020-12-09 08:03:01
Documents
16
Period of Report
2020-12-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prta-20201209.htm   iXBRL 8-K 40474
2 EXHIBIT 99.1 PRESS RELEASE DATED DECEMBER 9, 2020 prx004phase1pressrelas.htm EX-99.1 24820
7 GRAPHIC image_01.jpg GRAPHIC 6226
  Complete submission text file 0001559053-20-000045.txt   233532

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20201209.xsd EX-101.SCH 2436
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prta-20201209_cal.xml EX-101.CAL 722
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prta-20201209_def.xml EX-101.DEF 1659
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20201209_lab.xml EX-101.LAB 25800
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20201209_pre.xml EX-101.PRE 13686
9 EXTRACTED XBRL INSTANCE DOCUMENT prta-20201209_htm.xml XML 12265
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 201376933
SIC: 2834 Pharmaceutical Preparations